Altmetric

DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation

File Description SizeFormat 
Supplementary materials.pdfSupporting information1.58 MBAdobe PDFView/Open
4164-79577-1-PB.pdfPublished version4.76 MBAdobe PDFView/Open
Title: DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation
Authors: Faronato, M
Nguyen, VTM
Patten, DK
Lombardo, Y
Steel, JH
Patel, N
Woodley, L
Shousha, S
Coombes, RC
Magnani, LM
Item Type: Journal Article
Issue Date: 4-Jun-2015
Date of Acceptance: 16-May-2015
URI: http://hdl.handle.net/10044/1/23241
DOI: https://dx.doi.org/10.18632/oncotarget.4164
ISSN: 1949-2553
Publisher: Impact Journals
Start Page: 22467
End Page: 22479
Journal / Book Title: Oncotarget
Volume: 6
Issue: 26
Copyright Statement: © 2015 The Authors. Licensed under a Creative Commons Attribution 3.0 License.
Keywords: DMXL2
breast cancer
Notch
endocrine therapy
EMT
Publication Status: Published
Appears in Collections:Division of Surgery
Division of Cancer
Faculty of Medicine



This item is licensed under a Creative Commons License Creative Commons